IR vs RNTX · P/E 49, rev $7.65B vs $80.6M cap
Ingersoll Rand Inc (IR) versus Rein Therapeutics Inc (RNTX) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Latest reported IR revenue for 2025-12-31 was $7.65B. Net income was $581.4M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. RNTX currently screens at market cap $80.6M.
Not investment advice. Open the IR and RNTX stock pages for the full models.
Not investment advice.